Late-Breaking Clinical Trials

The ACC is now accepting submissions of Late-Breaking Clinical Trials to be presented at ACC.25, March 29 – 31, in Chicago! The deadline for all submissions is Thursday, Nov. 21 at 1 p.m. ET.

Late-Breaking Clinical Trial submissions are accepted in the following categories:

• Major Study
• Smaller Study/Randomized Clinical Trial
• Multi-center Observational Study or Registry
• Secondary Analysis of Major Clinical Trial
Other

Accepted Late-Breaking Clinical Trial submissions will be presented in person during one of six LBCT sessions in the Main Tent in Chicago and streamed live on the ACC.25 virtual platform. No video/virtual presentation option will be available.

Three LBCT sessions will be co-sponsored by the Journal of the American College of Cardiology (JACC), the Journal of the American Medical Association (JAMA) and the New England Journal of Medicine (NEJM). Each accepted submission will be considered for JACC Rapid Review and publication in JACC, JAMA and NEJM. In addition, each LBCT session will be followed by a press conference with top media outlets.